E-LIB Suche - Ergebnisse für: Kerguelen Fuentes, A. - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Treatment of hypertriglyceridemia by therapeutic plasma exc..:

Marín-Serrano, E. ; Kerguelen Fuentes, A. ; Fernández-Martos, R....
Pancreatology. 23 (2023) 7 - p. e7 , 2023

Link: https://doi.org/10.1016/..

2

Tratamiento de la hipertrigliceridemia grave mediante recam..:

Marín-Serrano, Eva ; Kerguelen Fuentes, Ana ; Fernández-Martos, Rubén...
Gastroenterología y Hepatología. , 2024

Link: https://doi.org/10.1016/..

3

Light‐chain amyloidosis presenting as a change in bleeding ..:

Montalbán‐Bravo, G. ; Kerguelen Fuentes, A. E. ; Canales Albendea, M. A....
Haemophilia. 21 (2014) 1 - p. , 2014

Link: https://doi.org/10.1111/..

4

Associations between gender, disease features and symptom b..:

H. Geyer ; H. Kosiorek ; A. Dueck...
info:eu-repo/semantics/altIdentifier/pmid/27540137. , 2017

Link: http://hdl.handle.net/24..

5

Symptom burden profile in myelofibrosis patients with throm..:

Scotch, Allison H. ; Kosiorek, Heidi ; Scherber, Robyn...
Leukemia Research. 63 (2017) - p. 34-40 , 2017

Link: https://doi.org/10.1016/..

6

A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-..:

Ramos-Ruperto, L. ; García-Pérez, Eduardo ; Hernández-Maraver, D....
SN Comprehensive Clinical Medicine. , 2021

Link: https://doi.org/10.1007/..

7

Associations between gender, disease features and symptom b..:

Geyer, Holly L ; Kosiorek, Heidi ; Dueck, Amylou C...
Haematologica, 0390-6078, 2017, 102:1, s. 85-93. , 2017

Link: http://urn.kb.se/resolve..

8

Associations between gender, disease features and symptom b..:

Geyer, Holly L ; Kosiorek, Heidi ; Dueck, Amylou C...
Reproducció del document publicat a: https://doi.org/10.3324/haematol.2016.149559. , 2017

Link: http://hdl.handle.net/24..

9

Symptomatic profiles of 1334 polycythemia vera patients: im..:

Geyer, Holly L ; Scherber, Robyn ; Kosiorek, Heidi...
Reproducció del document publicat a: https://doi.org/10.1200/JCO.2015.62.9337. , 2016

Link: http://hdl.handle.net/24..

10

Antiplatelet therapy versus observation in low-risk essenti..:

Álvarez Larrán, Alberto ; Pereira Saavedra, Arturo ; Guglielmelli, Paola...
Reproducció del document publicat a: https://doi.org/10.3324/haematol.2016.146654. , 2016

Link: http://hdl.handle.net/24..

11

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form T..:

Emanuel, Robyn M ; Dueck, Amylou C ; Geyer, Holly L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872304/. , 2012

Link: http://www.ncbi.nlm.nih...

12

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual Izquierdo, Cristina ; Mingot Castellano, María Eva ; Kerguelen Fuentes, Ana E...
2473-9529. , 2023

Link: http://hdl.handle.net/10..

13

Real-world effectiveness of caplacizumab vs the standard of..:

Izquierdo, Cristina Pascual ; Mingot-Castellano, María Eva ; Fuentes, Ana E. Kerguelen...
Blood Advances. 6 (2022) 24 - p. 6219-6227 , 2022

Link: https://doi.org/10.1182/..

14

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual Izquierdo, Cristina ; Mingot Castellano, María Eva ; Kerguelen Fuentes, Ana E...
Reproducció del document publicat a: https://doi.org/10.1182/bloodadvances.2022008028. , 2022

Link: http://hdl.handle.net/24..

15

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual, Cristina ; Mingot Castellano, María Eva ; Kerguelen Fuentes, Ana Esther...
Blood Advances;6(24). , 2022

Link: https://hdl.handle.net/1..

1-15